American Society of Clinical Oncology clinical expert statement on cancer survivorship care planning

Deborah K. Mayer, Larissa Nekhlyudov, Claire Snyder, Janette K. Merrill, Dana S. Wollins, Lawrence N. Shulman

Research output: Contribution to journalArticle

Abstract

The seminal report from the Institute of Medicine, "From Cancer Patient to Cancer Survivor: Lost in Transition," identified four essential components of survivorship care and recommended that a survivorship care plan (SCP), consisting of a treatment summary and follow-up care plan, be developed and used as a tool to deliver patient-centered care by enhancing communication between the oncology team and the patient as well as communication and coordination of care between the oncology team and the primary care provider (PCP). Nearly a decade ago, the American Society of Clinical Oncology (ASCO) initiated a series of activities to promote chemotherapy treatment plans and summaries and SCPs. Unfortunately, there has been limited success in implementing SCPs in oncology practice because of barriers including, but not limited to, the time-consuming process of completing an SCP, lack of role clarity, and lack of reimbursement for preparation time. ASCO developed this statement and revised template to provide a framework for completing and sharing SCPs and to set clear expectations for survivorship care planning in the oncology setting. This statement is intended to help clinicians recognize the importance of developing patientcentered SCPs and delivering the information to both the patient and PCP and to identify barriers that may exist in completing and delivering these documents effectively.

Original languageEnglish (US)
Pages (from-to)345-351
Number of pages7
JournalJournal of Oncology Practice
Volume10
Issue number6
DOIs
StatePublished - Nov 1 2014

Fingerprint

Survival Rate
Neoplasms
Primary Health Care
Communication
Patient-Centered Care
Aftercare
National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division
Medical Oncology
Survivors
Patient Care
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy
  • Medicine(all)

Cite this

American Society of Clinical Oncology clinical expert statement on cancer survivorship care planning. / Mayer, Deborah K.; Nekhlyudov, Larissa; Snyder, Claire; Merrill, Janette K.; Wollins, Dana S.; Shulman, Lawrence N.

In: Journal of Oncology Practice, Vol. 10, No. 6, 01.11.2014, p. 345-351.

Research output: Contribution to journalArticle

Mayer, Deborah K. ; Nekhlyudov, Larissa ; Snyder, Claire ; Merrill, Janette K. ; Wollins, Dana S. ; Shulman, Lawrence N. / American Society of Clinical Oncology clinical expert statement on cancer survivorship care planning. In: Journal of Oncology Practice. 2014 ; Vol. 10, No. 6. pp. 345-351.
@article{c6832d91193b4b769eae8582ea60d22d,
title = "American Society of Clinical Oncology clinical expert statement on cancer survivorship care planning",
abstract = "The seminal report from the Institute of Medicine, {"}From Cancer Patient to Cancer Survivor: Lost in Transition,{"} identified four essential components of survivorship care and recommended that a survivorship care plan (SCP), consisting of a treatment summary and follow-up care plan, be developed and used as a tool to deliver patient-centered care by enhancing communication between the oncology team and the patient as well as communication and coordination of care between the oncology team and the primary care provider (PCP). Nearly a decade ago, the American Society of Clinical Oncology (ASCO) initiated a series of activities to promote chemotherapy treatment plans and summaries and SCPs. Unfortunately, there has been limited success in implementing SCPs in oncology practice because of barriers including, but not limited to, the time-consuming process of completing an SCP, lack of role clarity, and lack of reimbursement for preparation time. ASCO developed this statement and revised template to provide a framework for completing and sharing SCPs and to set clear expectations for survivorship care planning in the oncology setting. This statement is intended to help clinicians recognize the importance of developing patientcentered SCPs and delivering the information to both the patient and PCP and to identify barriers that may exist in completing and delivering these documents effectively.",
author = "Mayer, {Deborah K.} and Larissa Nekhlyudov and Claire Snyder and Merrill, {Janette K.} and Wollins, {Dana S.} and Shulman, {Lawrence N.}",
year = "2014",
month = "11",
day = "1",
doi = "10.1200/JOP.2014.001321",
language = "English (US)",
volume = "10",
pages = "345--351",
journal = "Journal of Oncology Practice",
issn = "1554-7477",
publisher = "American Society of Clinical Oncology",
number = "6",

}

TY - JOUR

T1 - American Society of Clinical Oncology clinical expert statement on cancer survivorship care planning

AU - Mayer, Deborah K.

AU - Nekhlyudov, Larissa

AU - Snyder, Claire

AU - Merrill, Janette K.

AU - Wollins, Dana S.

AU - Shulman, Lawrence N.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - The seminal report from the Institute of Medicine, "From Cancer Patient to Cancer Survivor: Lost in Transition," identified four essential components of survivorship care and recommended that a survivorship care plan (SCP), consisting of a treatment summary and follow-up care plan, be developed and used as a tool to deliver patient-centered care by enhancing communication between the oncology team and the patient as well as communication and coordination of care between the oncology team and the primary care provider (PCP). Nearly a decade ago, the American Society of Clinical Oncology (ASCO) initiated a series of activities to promote chemotherapy treatment plans and summaries and SCPs. Unfortunately, there has been limited success in implementing SCPs in oncology practice because of barriers including, but not limited to, the time-consuming process of completing an SCP, lack of role clarity, and lack of reimbursement for preparation time. ASCO developed this statement and revised template to provide a framework for completing and sharing SCPs and to set clear expectations for survivorship care planning in the oncology setting. This statement is intended to help clinicians recognize the importance of developing patientcentered SCPs and delivering the information to both the patient and PCP and to identify barriers that may exist in completing and delivering these documents effectively.

AB - The seminal report from the Institute of Medicine, "From Cancer Patient to Cancer Survivor: Lost in Transition," identified four essential components of survivorship care and recommended that a survivorship care plan (SCP), consisting of a treatment summary and follow-up care plan, be developed and used as a tool to deliver patient-centered care by enhancing communication between the oncology team and the patient as well as communication and coordination of care between the oncology team and the primary care provider (PCP). Nearly a decade ago, the American Society of Clinical Oncology (ASCO) initiated a series of activities to promote chemotherapy treatment plans and summaries and SCPs. Unfortunately, there has been limited success in implementing SCPs in oncology practice because of barriers including, but not limited to, the time-consuming process of completing an SCP, lack of role clarity, and lack of reimbursement for preparation time. ASCO developed this statement and revised template to provide a framework for completing and sharing SCPs and to set clear expectations for survivorship care planning in the oncology setting. This statement is intended to help clinicians recognize the importance of developing patientcentered SCPs and delivering the information to both the patient and PCP and to identify barriers that may exist in completing and delivering these documents effectively.

UR - http://www.scopus.com/inward/record.url?scp=84911866164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84911866164&partnerID=8YFLogxK

U2 - 10.1200/JOP.2014.001321

DO - 10.1200/JOP.2014.001321

M3 - Article

C2 - 25316025

AN - SCOPUS:84911866164

VL - 10

SP - 345

EP - 351

JO - Journal of Oncology Practice

JF - Journal of Oncology Practice

SN - 1554-7477

IS - 6

ER -